<DOC>
	<DOCNO>NCT01472705</DOCNO>
	<brief_summary>This study seek investigate safety efficacy biolimus-eluting stent ( BES ) biodegradable polymer compare everolimus-eluting stent ( EES ) durable polymer 3 year follow-up .</brief_summary>
	<brief_title>Everolimus- Versus Biolimus-Eluting Stents All-Comers</brief_title>
	<detailed_description>A group 814 consecutive patient undergo percutaneous coronary intervention ( PCI ) enrol 2007 2010 , 527 treat EES 287 BES implantation . Clinical outcome compare 200 pair use propensity score matching . The primary endpoint composite death , myocardial infarction ( MI ) target vessel revascularisation ( TVR ) two-year follow-up .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>patient least one BES EES de novo stenosis patient least one nonstudy stent patient study stent patient life expectancy &lt; 3 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>drug-eluting coronary stent</keyword>
	<keyword>percutaneous coronary intervention</keyword>
</DOC>